TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03359174

An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“low recruitment”

The sponsor’s own words in the registry.

Life of this trial

201720182019202020212022Registered2017-11-27Started2018-05-29Primary completion2020-12-01Stopped2021-01-01Results posted2021-08-09

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Yale University
Sponsor type
University, hospital or other
Conditions
Cholangitis, Sclerosing
Interventions
All-trans retinoic acid
Participants
2
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.